These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Problems in current clinical psychopharmacology]. Nevzorova TA Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1218-22. PubMed ID: 5700589 [No Abstract] [Full Text] [Related]
43. [The signal function of motor side effects in psychopharmacotherapy from the viewpoint of correlative relations between motor activity, tonus and psyche]. Mucha H; König L; Kunath B; Winkler J Psychiatr Neurol Med Psychol (Leipz); 1971 Jul; 23(7):394-401. PubMed ID: 5120044 [No Abstract] [Full Text] [Related]
45. Drugs of choice for the emotionally ill. Nahum LH Conn Med; 1966 Mar; 30(3):165-9. PubMed ID: 5909889 [No Abstract] [Full Text] [Related]
46. [Psychopharmacotherapy in the adult psychiatric domain]. Bryois C Rev Med Suisse Romande; 2000 Feb; 120(2):123-9. PubMed ID: 10748698 [No Abstract] [Full Text] [Related]
47. Psychopharmacogenetics and psychiatric genetics: similar methodological challenges. Maziade M; Roy MA; Mérette C; Bissonnette L; Quirion R; Palmour R J Psychiatry Neurosci; 1999 May; 24(3):211-4. PubMed ID: 10354654 [No Abstract] [Full Text] [Related]
48. [Problems of quantitative evaluation and statistical analysis in psychopharmacology, Results and prospects in the clinical field]. Capitanucci P Arch Psicol Neurol Psichiatr; 1971; 32(4):312-22. PubMed ID: 5146163 [No Abstract] [Full Text] [Related]
49. Drug industry, psychopharmacology, and mental health care needs: where do we go from here? Segman R; Weizman A Isr J Psychiatry Relat Sci; 2008; 45(2):71-9. PubMed ID: 18982832 [No Abstract] [Full Text] [Related]
50. Better and safer pharmacotherapy for youth with psychiatric illness. Trivedi HK; Chang KD Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):xiii-xv. PubMed ID: 23040910 [No Abstract] [Full Text] [Related]
51. An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacology. DeVane CL; Liston HL Psychopharmacol Bull; 2001; 35(1):42-52. PubMed ID: 12397869 [TBL] [Abstract][Full Text] [Related]
52. [Change in the symptoms of psychiatric diseases. Significance of psychopharmacologic agents]. Reckel K Fortschr Med; 1971 Sep; 89(25):951-3. PubMed ID: 4949358 [No Abstract] [Full Text] [Related]
53. [Clinical psychopharmacology in 1966]. Vinar O Act Nerv Super (Praha); 1968 Feb; 10(1):65-84. PubMed ID: 4882491 [No Abstract] [Full Text] [Related]
54. The psychopharmacologic specificity of the lithium ion: origins and trajectory. Soares JC; Gershon S J Clin Psychiatry; 2000; 61 Suppl 9():16-22. PubMed ID: 10826656 [TBL] [Abstract][Full Text] [Related]
55. Pharmacotherapeutic census of a psychiatric hospital. II. A comparison with the data obtained one year ago. Vinaŕová M; Vinaŕ O; Antalovská M Act Nerv Super (Praha); 1967 Nov; 9(4):363-5. PubMed ID: 5612945 [No Abstract] [Full Text] [Related]